Alrakas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 103,263 | 147,030 | 92,123 | 113,873 | 113,199 | 124,749 | 146,559 | 196,267 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 25,167 | 56,410 | 21,981 | 25,369 | 23,659 | 15,554 | 9,837 | 37,226 |
| Equity | 2,954 | 2,954 | 2,954 | 29,453 | 43,016 | 37,325 | 38,162 | 49,389 |
| Liabilities | 4,301 | 4,708 | 1,395 | 4,164 | 4,303 | 6,485 | 7,671 | 7,078 |
| Non-current assets | 7,355 | 6,347 | 2,699 | 3,542 | 5,973 | 14,832 | 19,587 | 22,975 |
| Current assets | 27,840 | 61,665 | 27,137 | 30,075 | 41,346 | 28,978 | 26,246 | 33,492 |
| Total assets | 35,195 | 68,012 | 29,836 | 33,617 | 47,319 | 43,810 | 45,833 | 56,467 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 11,512 | 14,170 | 18,227 |
| Social insurance contributions | - | - | - | - | - | 3,842 | 14,103 | 6,752 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +96.3% | +42.4% | -37.3% | +23.6% | -0.6% | +10.2% | +17.5% | +33.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 71.5% | 82.9% | 73.7% | 75.5% | 50.0% | 35.5% | 21.5% | 65.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 852.0% | 1909.6% | 744.1% | 86.1% | 55.0% | 41.7% | 25.8% | 75.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 24.4% | 38.4% | 23.9% | 22.3% | 20.9% | 12.5% | 6.7% | 19.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.5 | 1.6 | 0.5 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 20,653 | 29,406 | 18,425 | 22,775 | 29,530 | 38,384 | 36,640 | 57,443 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Alrakas - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2021-11-16 | 2021-12-05 | 0.01 |
| 2021-11-05 | 2021-11-07 | 0.01 |
Alrakas - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-10-08 | 2024-10-16 | 4.66 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Alrakas, UAB (code 164688820) is a Private Limited Liability Company engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of €196.3K and net profit of €37.2K, giving a profit margin of 19.0%. Revenue increased by 33.9% year on year and by 57.3% over two years, showing a clear upward trend across 2023-2025. Profitability also improved after a softer 2024, when net profit was €9.8K, compared with €15.6K in 2023 and €37.2K in 2025. The balance sheet remained conservative at the end of 2025, with total assets of €56.5K, equity of €49.4K and liabilities of €7.1K. The equity ratio stood at 87.5%, while debt-to-equity was 0.14 and asset turnover was 3.48x. Return on equity was 75.4% and return on assets was 65.9%. Revenue per employee reached €65.4K and profit per employee €12.4K, indicating solid productivity in the latest financial year.